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INTRODUCTION
Development of mouse prostates is initiated at embryonic day 17
(E17) when a group of urogenital sinus epithelial cells derived from
the hindgut endoderm grow out into the surrounding urogenital sinus
mesenchyme in anterior, ventral, dorsal and lateral directions. These
buds subsequently form the anterior, ventral, dorsal and lateral
prostate lobes, respectively (Cunha et al., 2004; Thomson, 2001). At
postnatal day 1 (P1), solid prostatic buds are formed surrounding the
urethra. These buds already exhibit secondary and tertiary ductal
branches. The ducts then undergo extensive branching
morphogenesis, elongate from distal points and form intraductal
mucosal infolding. Approximately 80% of ductal branching is
completed by day 10 of neonatal life in mice, and the whole process
is normally completed in 60-90 days. During the developmental
stage, the epithelial cells differentiate into luminal secretory epithelial
cells, basal epithelial cells and neuroendocrine cells, concurrent with
the differentiation of mesenchyme into smooth muscle cells and
fibroblasts (Cunha et al., 2004; Hayward et al., 1997).
Adult prostates are androgen-dependent organs with respect to
growth, tissue homeostasis and function. Normally, the epithelium
rapidly regresses to an atrophic state upon depletion of androgens.
Approximately 35% of the ductal tips and branch-points are lost in
distal regions within 2 weeks after orchiectomy. Androgen
replenishment induces active cellular proliferation in the epithelium
of atrophied prostate within 2 days, and the epithelial ducts
completely regenerate within 14 days (Sugimura et al., 1986b).
Because tissue-recombination experiments showed that the
androgen receptor (AR) in epithelial cells is not essential for
prostates to respond to androgens, it is proposed that paracrinal
growth factors between stromal and epithelial compartments
mediate at least some of the regulatory functions of androgen, and
are crucial for androgens to instruct epithelial cells undergoing
proliferation and differentiation (Cunha, 1996; Cunha et al., 2004;
McKeehan et al., 1998; Thomson, 2001). Reciprocal
communication from epithelia to mesenchyme may also play similar
roles in stroma development, particularly in the differentiation to
smooth muscle cells (Cunha, 1994; Cunha et al., 1996; Cunha et al.,
2004; Hayward et al., 1998; Jin et al., 2004). It remains unresolved
whether androgens regulate growth, tissue homeostasis and tissue
functions via similar signaling mechanisms, although the FGF
signaling axis has been implicated to be important for androgen
signaling in prostates.
The mammalian FGF family consists of at least 22 gene products
that control a wide spectrum of cellular processes. Most FGFs bind
and activate transmembrane tyrosine kinases receptors (FGFRs)
encoded by four highly conserved genes that exhibit a variety of splice
variants (McKeehan et al., 1998; Powers et al., 2000; Wang and
McKeehan, 2003). Expression of FGFs and FGFRs is
spatiotemporally-specific in embryos and tissue- and cell-type-
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specific in adults. Aberrant activations of FGF signaling pathways are
found in developmental disorders and in diverse adult-tissue-specific
pathologies, including malignant cancer (McIntosh et al., 2000;
McKeehan et al., 1998; Ornitz, 2000; Wang and McKeehan, 2003).
In prostate, members of the FGF family and alternative splice forms
of FGFRs are partitioned in the epithelium and mesenchyme (stroma),
mediating directional and reciprocal communications between the two
compartments. Ablation of this two-way communication in mature
prostates perturbs tissue homeostasis and leads to prostatic
intraepithelial neoplasia (PIN) and progressively more-severe lesions
(Jin et al., 2003a; McKeehan et al., 1998). In addition, a series of
stepwise changes in FGF signaling contributes to the progression of
prostate lesions, including a reduction in resident FGFR2 expression
accompanied by the expression of ectopic epithelial FGFR1 (Jin et al.,
2003a; Kwabi-Addo et al., 2001; Lu et al., 1999; McKeehan et al.,
1998; Pirtskhalaishvili and Nelson, 2000). Additionally, changes in
the expression of FGF1, FGF2 (Ropiquet et al., 1999), FGF6
(Ropiquet et al., 2000), FGF8 (Dorkin et al., 1999; Gnanapragasam et
al., 2002; Song et al., 2002; Wang et al., 1999), FGF9 (Giri et al.,
1999b) and FGF17 (Polnaszek et al., 2004) have been observed to be
associated with prostatic lesions.
During prostatic organogenesis, messenger mRNAs for both
FGF7 and FGF10 are localized in the mesenchyme, and the
receptors for FGF7 or FGF10 are found in the epithelium of the
urogenital sinus in embryos and in the distal signaling center of
elongating and branching ducts in postnatal prostates (Huang et al.,
2005; Thomson and Cunha, 1999). Both FGF7 and FGF10 can
substitute for androgens in organ culture of neonatal prostates,
supporting extensive epithelial growth and ductal-branching
morphogenesis. Ablation of Fgf10 alleles abrogates prostate
development and diminishes androgen responsiveness of prostatic
rudiments in organ-culture and tissue-recombination experiments
(Donjacour et al., 2003). This suggests that FGF10 signaling is
essential for prostate development. Although it is generally accepted
that the FGFR2IIIb isoform is the primary receptor for FGF10, the
inability of mice deficient in FGFR2 to survive has prevented a
direct analysis of the function of FGFR2 in prostate development,
maintenance of homeostasis and androgen dependency.
To overcome this limitation, we specifically disrupted Fgfr2 alleles
in prostate precursor cells at E17.5. Unlike normal prostates, which
are composed of two anterior, two dorsal, two lateral and two ventral
lobes, most young-adult Fgfr2cn mice developed a small prostate that
was frequently limited to two dorsal and two lateral lobes.
Development of the epithelial compartment in Fgfr2cn prostates was
impaired, which could be characterized by a deficiency in
intralumenal infolding. In contrast to wild-type prostates,
maintenance of mature Fgfr2cn prostates was not strictly androgen
dependent. No significant prostatic atrophy was observed 2 weeks
after castration in adult Fgfr2cn mice. Similarly, androgen
replenishment to the castrated males also failed to induce cell
proliferation in Fgfr2cn prostates. The results showed that FGFR2
signals were essential for strict androgen dependency in adult
prostates with respect to tissue homeostasis. Interestingly, as in
control prostates, the production of secretory proteins in Fgfr2cn
prostates was dramatically reduced by androgen deprivation,
suggesting that regulation of the secretory function by androgen
remained in these prostates. Together, the data suggest that androgens
may elicit regulatory functions in the prostate via multiple pathways.
Thus, Fgfr2cn prostates provide a useful animal model for
scrutinizing the molecular mechanisms by which androgens regulate
prostate growth, homeostasis and function, and may yield clues as to
how advanced-tumor prostate cells escape strict androgen regulation.
MATERIALS AND METHODS
Animals
All animals were housed in the Program of Animal Resources of the Institute
of Biosciences and Technology, and were handled in accordance with the
principles and procedure of the Guide for the Care and Use of Laboratory
Animals. All experimental procedures were approved by the Institutional
Animal Care and Use Committee. The mice carrying LoxP-flanked Fgfr2
alleles, the ROSA26 reporter and the NKX3.1 (also known as NKX3-1)-Cre
knock-in alleles were bred and genotyped as described (Jin et al., 2003b;
Soriano, 1999; Yu et al., 2003). Orchiectomy and prostate regeneration were
carried out as described previously (Donjacour and Cunha, 1988; Jin et al.,
2003a; Wang et al., 2004). Serum levels of androgens in Fgfr2cn and control
littermates were measured with the DSL-400 Androgen Assessment kit
(Diagnostic Systems Laboratories, Webster, TX).
Collection of prostate tissues and histology analysis
The urogenital complex was excised from mice at the indicated ages and
fixed with 4% paraformaldehyde-PBS solution for 30 minutes. The
prostates were then dissected from the urogenital tracks under a stereo
microscope, weighted and further fixed for an additional 4 hours (Jin et al.,
2003a; Wang et al., 2004). In some cases, when comparisons of individual
lobes between mutant and control prostates were needed, each individual
lobe was dissected and fixed separately. Fixed tissues were serially
dehydrated with ethanol, embedded in paraffin and completely sectioned
according to standard procedures. Immunohistochemical analyses were
performed on 7 m paraffin sections mounted on Superfrost/Plus slides
(Fisher Scientific, Pittsburgh, PA). The antigens were retrieved by
autoclaving in Tris-HCl buffer (pH 10.0) for 5 minutes or as suggested by
the manufacturers of the antibodies. The source and concentration of
primary antibodies are: mouse anti-cytokeratin 8 (1:15 dilution) from
Fitzgerald (Concord, MA); mouse anti-smooth muscle -actin (1:1
dilution) and mouse anti-PCNA (1:1000 dilution) from Sigma (St Louis,
MO); mouse anti-p63 (1:150 dilution) and mouse anti-AR (1:150 dilution)
from Santa Cruz (Santa Cruz, CA); rabbit anti-probasin (1:3000 dilution)
from the Greenberg laboratory; and rabbit anti-PSP94 (1:2000 dilution)
from the Xuan laboratory. Total numbers of stained cells from a minimum
of three sections per prostate and at least three prostates per genotype were
scored for statistical analyses.
For whole-mount lacZ staining, the urogenital sinuses were lightly fixed
with 0.2% glutaraldehyde for 30 minutes and incubated overnight with 1
mg/ml X-Gal at room temperature, as described (Liu et al., 2005). For
TUNEL assay, tissues were fixed and sectioned as described above, and the
apoptotic cells were detected with the ApopTag Peroxidase In Situ Kit
(Chemicon, Temecula, CA). 
Micro-dissections of the prostate were performed according to Sugimura
(Sugimura et al., 1986a). Briefly, individual ductal networks of the prostate
gland were micro-dissected after incubation in 1% collagenase-PBS at 4°C
overnight. All micro-dissections were performed under a dissection
microscope. Numbers of the main ducts and distal ductal tips were scored
for statistical analyses.
Secreted protein analyses
The urogenital complex was excised from the mice as described above, and
the prostate was dissected from the urogenital complex in PBS. After being
dried with paper towels to remove excessive PBS, the prostate was diced
with scissors in 100 l PBS containing 1 mM PMDF. The PBS-extracted
secretory proteins were collected by centrifugation as described (Bhatia-
Gaur et al., 1999). The protein concentration of the collected sample was
normalized with PBS to a final concentration of 1 mg/ml. Samples
equivalent to 25 g of protein were separated on a 5-20% gradient SDS
PAGE, and the secretory proteins were visualized with Coomassie Brilliant
Blue staining. 
In situ hybridization and reverse transcriptase-PCR
For in situ hybridization, paraffin-embedded tissue sections were rehydrated
and digested with protease K for 7 minutes at room temperature. After
prehybridization at 70°C for 2 hours, the hybridization was carried out by
overnight incubation at 70°C with 0.5 g/ml digoxigenin-labeled RNA
probes specific for the FGFR2IIIB isoform. After being washed four times,
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each for 30 minutes, with 0.1DIG washing buffer at 65°C, specifically
bound probes were detected by the alkaline phosphatase-conjugated anti-
digoxigenin antibody (Roche, Indianapolis, IN). For reverse transcriptase
(RT)-PCR analyses, total RNA was extracted from dorsolateral prostates
with the RNeasy Mini Kit (QIAGEN, Valencia, CA). Reverse transcriptions
were carried out with SuperScript II (GIBCO-BRL, Life Technologies,
Grand Island, NY) and random primers according to protocols provided by
the manufacturer. RT-PCR was carried out for 30 and 35 cycles, as indicated,
at 94°C for 1 minute, 55°C for 1 minute and 72°C for 1 minute with Taq
DNA Polymerase (Promega, Madison, WI) and specific primers listed in
Table 1. RT-PCR products were analyzed on 2% agarose gels, and the
representing data from at least three repetitive experiments were shown.
Real-time RT-PCR analyses were carried out with the SYBR Green
JumpStart Taq ReadyMix (Sigma) as suggested by the manufacturer.
Relative abundances of mRNA were calculated using the comparative
threshold (CT) cycle method and normalized with -actin as an internal
control. Data were the means of three individual experiments. 
RESULTS
Tissue-specific disruption of Fgfr2 in the prostatic
epithelium
To determine whether FGFR2 was essential for prostatic
development, the LoxP-Cre recombination system was used to
conditionally inactivate the Fgfr2 alleles in epithelial cells of the
urogenital sinus at late embryonic stages (E17.5) by crossing mice
carrying LoxP-flanked Fgfr2 (Fgfr2flox) alleles (Fig. 1A) (Yu et al.,
2003) with those carrying an NKX3.1-Cre knock-in allele (Y.P.H.,
S. M. Price, Z. Chen, W. A. Banach-Petrosky, C. Abate-Shen and
M.M.S., unpublished). Deletion of the sequence for exon 8-10
generated a defective allele encoding a truncated FGFR2
ectodomain, as illustrated in Fig. 1B. These epithelial cells later gave
rise to prostate epithelial cells. Mice carrying homozygous Fgfr2flox
and NKX3.1-Cre alleles were viable, fertile and had no apparent
pathology. The prostates of mice carrying homozygous Fgfr2flox
alleles, or heterozygous Fgfr2flox alleles with or without the NKX3.1
knock-in allele, had no noticeable differences in gross tissue
morphology and histological structures from that of wild-type mice,
and therefore were considered as control prostates, although only
homozygous Fgfr2flox mice were used as controls in most of the
study.
Disruption of the Fgfr2 gene in the prostate of 3-week-old males
was confirmed by PCR analysis for the absence of the LoxP-flanked
exons (Fig. 1C). RT-PCR analyses of prostates in 7-day-old Fgfr2cn
mice with FGFR2IIIB-specific primers showed that expression of
FGFR2IIIB was below the detection limit; the same experiments
with FGFR2IIIC-specific primers or common primers for both
FGFR2IIIB and FGFR2IIIC isoforms showed that expression of
FGFR2 was significantly reduced in Fgfr2cn prostates (Fig. 1D),
indicating that the residual FGFR2 expression was due to expression
of the FGFR2IIIC isoform in stromal cells or other minor cell
populations. Similar results were derived from 3-week-old prostates
(data not shown). Furthermore, in situ hybridization with
FGFR2IIIB-specific probes showed that the expression of FGFR2
was diminished in the prostate epithelium at 3 weeks (Fig. 1E).
Morphological examination revealed that Fgfr2cn mice had a notably
smaller prostate compared with wild-type mice. Only small and thin
dp and lp lobes were apparent in the Fgfr2cn prostates, which were
also more transparent than control prostates. Because Fgfr2cn dp and
lp lobes were small and closely connected, rendering them difficult
to separate, the dp and lp lobes were collectively referred to as dlp
lobes. Among the 45 Fgfr2cn prostates examined at different ages,
42 exhibited only two dlp lobes. As for the remaining three mice, in
addition to two dlp lobes, one mouse also had a very small anterior
lobe, one had a ventral lobe, and one had two small anterior and one
ventral lobe. Subsequent analyses were mostly performed with the
dlp lobes.
Disruption of Fgfr2 alleles in the prostate
epithelium inhibited prostatic bud-branching
morphogenesis
To visualize better the defects in prostatic development in Fgfr2cn
mice, the ROSA26 reporter allele (Soriano, 1999) was bred into
Fgfr2flox/NKX3.1-Cre mice. The disruption of Fgfr2flox alleles
should occur concurrently with activation of the lacZ reporter by
excision of the floxed cassette in ROSA26 alleles. The lower
urogenital track was then dissected from embryos and newborn pups
for whole-mount staining with X-Gal (Fig. 2A). Because the
expression of NKX3.1-Cre is initiated in urogenital sinus epithelial
cells that give rise to prostate epitheliums between E17.0-E17.5
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Table 1. Nucleotide sequence of primers (5-3)
-actin GCACCAAGGTGTGATGGTG and GGATGCCACAGGATTCCATA
BMP4 AGGAGGAGGAGGAAGAGCAG and TGTGATGAGGTGTCCAGGAA
BMP7 ACCTGGGCTTACAGCTCTCTGT and CGGAAGCTGACGTACAGCTCATG
-catenin GGTGGACTGCAGAAAATGGT and TCGCTGACTTGGGTCTGTCA
FGF7 GGTGAGAAGACTGTTCTGTC and GTGTGTCCATTTAGCTGATG
FGF10 TGTGCGGAGCTACAATCACC and GATGCATAGGTGTTGTATCC
FGFR2 GGGAAGGAGTTTAAGCAGGAGCAT and CTTCAGGACCTTGAGGTAGGGCAG
FGFR2IIIB GCACTCGGGGATAAATAGCTC and TGTTACCTGTCTCCGCAG
FGFR2IIIC AGCTGCCGGTGTTAACACCAC and TGTTACCTGTCTCCGCAG
Foxa1 CCATGAACAGCATGACTGCG and TCGTGATGAGCGAGATGTAGGA
Foxa2 GTGAAGATGGAAGGGCTCGA and AGACTCGGACTCAGGTGAGG
Gapdh GGTGGAGCCAAAAGGGTCAT and GGCCATCACGCCACAGCTTT
Gli1 GAAGGAATCCGTGTGCCATT and GGATCTGTGTAGCGCTTGGT
Gli2 GGCACCAACCCTTCAGACTA and CTGAGCTGCTCCTGGAGTTG
Gli3 GTCAGCCCTGCGGAATACTA and GGAACCACTTGCTGAAGAGC
HoxB13 GATGTGTTGCCAAGGTGAACA and TGAAACCAGATGGTAATCTGGCG
HoxD13 GCAAGAGCCAAGGAAGTGTC and TCGGTAGACGCACATGTCCG
Nkx3.1 ATTGTTCCGTGTCCCTTGTT and GTTTCTACCAGTTCAGGTGT
Notch1 CCCACTGTGAACTGCCCTAT and CACCCATTGACACACACACA
Ptch1 TCAACCCAGCCGACCCAGATT and CCCTGAAGTGTTCATACATTTGCTTGG
Shh ACATCCACTGTTCTGTGAAAGCA and TCTCGATCACGTAGAAGACCTTCTTGG
TGF-1 CTAATGGTGGACCGCAACAA and GTACAACTCCAGTGACGTCA
Wnt1 AAGATCGTCAACCGAGGCTG and CATTTGCACTCTTGGCGCAT
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(Y.P.H., S. M. Price, Z. Chen, W. A. Banach-Petrosky, C. Abate-
Shen and M.M.S., unpublished), X-Gal staining was not visible prior
to day E17.0, and was only weakly visible at E17.25 in a group of
cells surrounding the urethra (data not shown). The staining became
more prominent at day E17.5 in cells protruding in different
directions, which represent cells giving rise to the prostatic
epithelium (Fig. 2A). At this stage, both Fgfr2cn and control
embryos developed well-defined ap, dlp and vp buds; no significant
difference in X-Gal-staining patterns was observed between Fgfr2cn
and control animals. At E18.5, the X-Gal-stained cells in control
mice expanded in anterior, dorsolateral and ventral directions (Fig.
2A). By contrast, the same cells in Fgfr2cn mice failed to expand in
both anterior and ventral directions, so that the ap and vp buds
remained similar to those in E17.5 embryos. Only the cells in dorsal
and lateral directions expanded and developed into the dp and lp
lobes, respectively. The discrepancy in ap and vp bud formation in
Fgfr2cn and control mice became more significant at newborn
stages. Only the expanding dlp lobes were visible at P5 (Fig. 2A).
To further study the Cre expression pattern, the X-Gal stained tissues
were paraffin embedded and sectioned (Fig. 2A, insert; and data not
shown). The result showed that expression of lacZ was activated
homogenously in the epithelia compartment in every lobe of Fgfr2cn
and control prostate, indicating that NKX3.1-Cre efficiently and
uniformly excised the silencing cassette in the ROSA26 locus in
epithelial cells in every prostatic bud (Fig. 2A). It is expected that
the floxed Fgfr2 alleles were similarly inactivated in all prostatic
buds at the same time. Thus, the results imply that FGFR2 signals
are more crucial for branching morphogenesis of ap and vp lobes
than of dlp lobes, although the underlying molecular mechanism is
not clear. 
Disruption of Fgfr2 alleles in prostate epithelium
inhibits branching morphogenesis and growth of
epithelial ducts
To continue tracking prostate development in Fgfr2cn mice, prostate
tissues and the adjacent urethra were dissected from these mice at 2,
4 and 6 weeks of age. Although always smaller and more transparent
than normal prostates, Fgfr2cn prostates substantially increased in
size during pubertal development (Fig. 2B). The prostate is mainly
composed of epithelial ducts packed tightly into a lobular structure.
To determine whether the Fgfr2cn prostates had fewer or smaller
ducts than control prostates, the dorsolateral lobes of both Fgfr2cn
and control prostates were treated with collagenase, and the
epithelial ducts were subsequently separated (Fig. 2B,B). The
number of main ducts and total number of distal ductal tips were
then quantified. The results revealed that Fgfr2cn prostates had fewer
ducts than the controls. The average number of main ducts in the
Fgfr2cn dorsolateral prostates was 7.2, compared with 12.5 in control
prostates (P<0.05). The average number of distal ductal tips in
Fgfr2cn prostates was 58, compared with 113 in control prostates
(P<0.01). Furthermore, the Fgfr2cn ducts were shorter in length and
smaller in diameter than those of the control prostates. This indicates
that the disruption of FGFR2 in prostatic bud epithelial cells
inhibited both ductal-branching morphogenesis and growth of
epithelial ducts.
To investigate whether the FGFR2 kinase was required for rapid
growth of prostate cells during pubertal development, proliferating
cells in Fgfr2cn and control prostates at the ages of 2, 4 and 6 weeks
were assessed by the immunostaining of proliferating cell nuclear
antigen (PCNA). At pre-pubertal age (2 weeks), the proliferating
cells were mainly localized at the distal tips in both Fgfr2cn and
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Fig. 1. Disruption of the Fgfr2 alleles in prostate
epithelium. (A) Schematic of the floxed Fgfr2 alleles
for conditional disruption. The genomic DNA containing
exons 6-10 and the adjacent introns is shown. The
primers for PCR genotyping and FGFR2 expression
analyses are indicated. (B) The Fgfr2cn alleles only
encode a truncated ectodomain. (C) PCR genotyping.
Genomic DNAs extracted from different lobes of Fgfr2cn
and control prostates of 3-week-old mice were PCR
analyzed with the indicated primers. Primers f1 and f2
amplify a fragment of 207 bp from floxed Fgfr2 alleles.
Primers f1 and f3 amplify a fragment of 471 bp from
Fgfr2-null alleles, and give no amplification for wild-type
Fgfr2 or Fgfr2flox alleles. (D,E) Diminished FGFR2
expression in the epithelium of Fgfr2cn prostates. The
expression of FGFR2 was assessed with RT-PCR (D) and
in situ hybridization (E). Primers R2f and R2r amplify
both FGFR2IIIb (IIIb) and FGFR2IIIc (IIIc) isoforms; primers
b and t only amplify FGFR2IIIb isoform, primers c and t
only amplify FGFR2IIIc isoform. –, negative control
without cDNA templates. Panel E shows strong
expression of FGFR2 in the epithelial compartment of
control prostates, which was diminished in Fgfr2cn
prostates. ap, anterior prostate; dlp, dorsolateral
prostate; vp, ventral prostate; S, signal peptide; I/II/III,
immunoglobulin loop I, II and III, respectively; TM,
transmembrane domain; F/F, homozygous Fgfr2flox mice;
CN, Fgfr2cn mice.
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control prostates (Fig. 2C). Data from three individual prostates
showed that approximately 34.2±5.0% of epithelial cells in Fgfr2cn
prostates and 36.2±4.4% in control prostates were actively engaged
in proliferation. No significant difference was observed at this stage
(P>0.05). At the age of 4 weeks, when the mice were undergoing
rapid pubertal growth, the proliferating cells were widely distributed
in the whole prostate. At this stage, the population of proliferating
cells in Fgfr2cn prostates was significantly smaller than that in
control prostates (17.8±1.2% in Fgfr2cn prostate and 35.4±3.5% in
control prostate, P<0.01). At the post-pubertal age (6 weeks), the
proliferating cell population in both Fgfr2cn and control prostates
was dramatically reduced (2.00±0.01% in Fgfr2cn prostate and
2.20±0.05% in control prostate, P>0.05), indicating that both
Fgfr2cn and control prostates were mature at this stage. Together, the
result demonstrates that ablation of Fgfr2 in prostate epithelium
impaired cellular proliferation during pubertal growth.
Fgfr2cn prostates had an underdeveloped
epithelium compartment with reduced basal cell
population
Epithelial cells in each prostatic lobe normally exhibit a lobe-
specific infolding and cellular morphology. Histological analyses
showed that Fgfr2cn prostate had less epithelial infolding compared
with control prostates, especially in the anterior and dorsolateral
lobes (Fig. 3A). The epithelial cells were less polarized with reduced
columnarization, suggesting that a deficiency in resident FGFR2
disrupted the completion of terminal differentiation in the
epithelium. Notably, among the two adult Fgfr2cn males having
poorly developed ap lobes in the prostates (out of 45 Fgfr2cn mice
examined), one had two ap lobes that exhibited a tissue structure
similar to that of seminal vesicles (Fig. 3A and see Fig. S1 in the
supplementary material); the other mouse only had one lobe that had
a tissue structure similar to the prostatic bud of newborn mice (data
not shown). Nevertheless, semi-quantitative RT-PCR (Fig. 3B) and
real-time RT-PCR (Fig. 3C) analyses of total RNA samples extracted
from 3-week-old dorsolateral prostates revealed that ablation of
Fgfr2 in the prostate epithelium did not significantly alter the
expression of key regulatory molecules for prostate organogenesis
and growth, however, the expressions of BMP4, TGF- and
HOXD13 were somewhat reduced in Fgfr2cn prostates. Data from
real-time RT-PCR confirmed that the expression of BMP4 in Fgfr2cn
prostates was reduced by 55% (P<0.001), TGF- by 53% (P<0.001)
and HOXD13 by 58% (P<0.001). Similar to the data in Fig. 3B, real-
time RT-PCR data also showed no significant difference in
expression levels of all other tested molecules between Fgfr2cn and
control prostates (data not shown). 
727RESEARCH ARTICLEFGFR2 in prostate development
Fig. 2. Disruption of Fgfr2 alleles leads to perturbed prostate morphogenesis. (A) The urogenital sinuses were dissected from embryos or
postnatal pups carrying ROSA26/NKX3.1-Cre, and Fgfr2flox or wild-type Fgfr2 alleles at the indicated days. The tissues were lightly fixed and stained
with X-Gal, as described. The stained tissues representing each prostatic lobe are indicated. Notice no significant difference exists in prostatic buds
at E17.5 between Fgfr2cn and wild-type controls. Insert: section from the same tissue showing that NKX3.1-Cre efficiently excised the silencing
cassette of the ROSA26 allele. (B) The prostate and urethra were dissected from mice at the indicated ages (left panels). Right panels: dorsolateral
prostate lobes dissected from tissues shown in left panels. (B,B) Epithelial ducts were dissected from dorsolateral prostates of 6-week-old mice
with the indicated genotypes. (C) The prostate tissues were collected from Fgfr2cn and control mice at the indicated ages, and proliferating cells
were identified immunohistochemically by expression of PCNA. Inserts: high-magnification views from the same sections. ap, anterior prostate; dlp,
dorsolateral prostate; vp, ventral prostate; u, urethra; b, bladder; s, seminal vesicle; F/F, homozygous Fgfr2flox mice; CN, Fgfr2cn mice. Scar bars:
2 mm.
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The epithelial compartment of mature prostates mainly consists of
well-differentiated luminal epithelial cells that express cytokeratin 8,
and basal epithelial cells that express p63 (Cunha et al., 2004; Kurita
et al., 2004). The stromal compartment largely consists of smooth
muscle cells that express -actin and are keratin-deficient. To
determine whether Fgfr2cn prostates also express these characteristic
markers, tissue sections were immunochemically analyzed with
antibodies against cytokeratin 8, -actin and p63. The epithelial and
stromal cells in Fgfr2cn prostates expressed cytokeratin 8 and -actin,
respectively, at levels similar to that seen in control prostates (Fig. 4A).
By contrast, the population of p63-positive basal cells in Fgfr2cn
prostates was significantly reduced compared with controls, both in
growing and mature prostates (Fig. 4B,C). To quantitate the ratio of
basal:luminal cells, p63-positive cells in the three sections per prostate
were scored. Data from three individual experiments showed that the
mean ratios of basal:luminal epithelial cells were 0.48 and 0.67
(P<0.001) in 2-week-old, 0.24 and 0.48 (P<0.001) in 4-week-old, and
0.20 and 0.34 (P<0.001) in 6-week-old Fgfr2cn and control prostates,
respectively, which validated the observation that the basal cells were
reduced in Fgfr2cn prostates. 
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Fig. 3. Fgfr2cn prostates exhibited basic prostate
characteristics. (A) Prostate tissues from 6-week-old mice
were sectioned and stained with HE for histological
analyses. Inserts: high-magnification views from the same
tissues. (B) Total RNAs were extracted from dorsolateral
prostates of 3-week-old mice and reverse translated with
random hexanucleotide primers. RT-PCR was performed as
indicated, with -actin and Gapdh as internal standards.
Cycle numbers of amplification are indicated at the top.
(C) Real-time RT-PCR analyses of the same panel of
molecules as in B. Data were normalized with -actin
loading control and were expressed as folds of difference
from the control prostates. Data were means of triplicate
samples. *P<0.001. F/F, homozygous Fgfr2flox mice; CN,
Fgfr2cn mice; ap, anterior prostate; dp, dorsal prostate; lp,
lateral prostate; vp, ventral prostate. 
Fig. 4. Immunohistochemical
characterization of the Fgfr2cn
prostate. (A) The prostate
sections from 4-week-old mice
were immunostained with anti--
actin or anti-cytokeratin 8, as
indicated. (B) Prostate sections
from Fgfr2cn and control mice at
the indicated ages were
immunohistochemically stained
with anti-p63 antibodies. Inserts:
high-magnification views from the
same section. (C) Ratios of p63-
positive cells in the epithelial
compartment were calculated
from three samples. Data
representing means and s.d. of
triplicate samples. F/F,
homozygous Fgfr2flox mice; CN,
Fgfr2cn mice.
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Ablation of Fgfr2 diminished androgen
dependency with respect to maintenance of
tissue homeostasis, but not to production of the
secretory proteins in prostates
Androgens are crucial for prostate development, tissue
homeostasis and for the production of secretory proteins. To
ascertain whether Fgfr2cn mice were deficient in androgens,
serum androgen levels in Fgfr2cn and control littermates were
determined. No significant difference in serum androgens was
observed. The average androgen concentration in Fgfr2cn serum
was 7.35±8.00 ng/ml (n=12), and that of control was 8.9±9.1
ng/ml (n=12). Thus, the defect in Fgfr2cn prostate development
was not a result of androgen insufficiency. To determine whether
androgen was required for maintaining tissue homeostasis in
Fgfr2cn prostates, mice at the age of 6 weeks were orchiectomized
to deprive the mice of androgens. Apoptotic cells in the prostates
were subsequently assessed with TUNEL analyses (Fig. 5A). The
results showed that apoptotic cells were seldom observed in
Fgfr2cn and control prostates prior to the castration. Apoptotic
cells appeared in the epithelial compartment of control prostates
within 1 day after castration and became more abundant in days
2-4 post-castration. By sharp contrast, only a limited number of
apoptotic cells were detected in the epithelial compartment of
Fgfr2cn prostates, indicating that the maintenance of cellular
homeostasis in Fgfr2cn prostates did not depend on androgen as
stringently as in control prostates. Hematoxylin and Eosin (HE)
staining further demonstrated significant tissue atrophy in the
prostate of castrated control, but not the Fgfr2cn, males (Fig. 5B).
To investigate whether ARs are expressed similarly in control
and Fgfr2cn prostates, immunostaining with anti-AR antibodies
was carried out. The results revealed that both stromal and
epithelial cells in Fgfr2cn prostates expressed AR at levels
comparable to that detected in control prostates. As in control
prostates, the majority of the AR was located in the nucleus of
Fgfr2cn prostate epithelial cells, indicating no abnormality in
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Fig. 5. Diminished androgen
dependency in Fgfr2cn prostates
with respect to tissue homeostasis.
(A) Fgfr2cn and control mice were
orchiectomized to eliminate testis-
derived androgens. At the indicated day
after the operation, the prostate tissues
were harvested and apoptotic cells were
detected with TUNEL assay. (B) HE
staining of the same tissues showing
that castration failed to induce tissue
atrophy in Fgfr2cn prostates. F/F,
homozygous Fgfr2flox mice; CN, Fgfr2cn
mice.
Fig. 6. Expression of the androgen receptor in Fgfr2cn prostates.
Prostates were harvested from 6-week-old mice before (0 day) and at
the indicated days after the castration. Expression and cellular
localization of the AR were assessed with immunostaining with anti-AR
antibodies. Notice that a considerable amount of AR in Fgfr2cn
prostates remained in the nuclei at day 14 after the castration. ap,
anterior prostate; dp, dorsal prostate; lp, lateral prostate; vp, ventral
prostate; F/F, homozygous Fgfr2flox mice; CN, Fgfr2cn mice.
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either AR expression or nuclear translocation (Fig. 6). To further
investigate whether Fgfr2cn prostates had defects in the
subcellular localization of AR after androgen deprivation, prostate
sections from castrated control and Fgfr2cn mice were
immunostained with anti-AR antibodies. The results showed that,
14 days after androgen deprivation, most of the AR in control
prostates could be found in cytoplasm only (Fig. 6), which is
similar to what has previously been reported (Lee and Chang,
2003). However, even 14 days after the castration, a significant
amount of AR was still localized in the nucleus of Fgfr2-deficient
epithelial cells (Fig. 6), which was in sharp contrast to control
prostates, which exhibited no nuclear-localized AR at this time
point. The prolonged nuclear localization of the AR in Fgfr2cn
prostates may explain why the mutant prostates were less
androgen dependent, although the detailed molecular mechanism
underlying this phenotype remains to be elucidated. 
At 2 weeks after orchiectomy, control prostates underwent
tissue atrophy and had a significant change in gross tissue
appearance. Consistent with failing to induce apoptosis, androgen
deprivation also failed to induce significant tissue morphological
changes in Fgfr2cn prostates (Fig. 7A). HE staining of tissue
sections verified that no obvious changes in tissue morphology of
Fgfr2cn prostates could be observed 14 days after the orchiectomy
(Fig. 7B). To further examine the effects of androgen in Fgfr2cn
prostates, time-release testosterone pellets were implanted into
mice 2 weeks after orchiectomy. The prostates were then
harvested from day 1 to day 14 after androgen replenishment for
histological analyses. Results showed that androgen
replenishment induced massive cellular proliferation in control
prostates within 2 days (Fig. 7C,D), and tissue architecture was
restored by 2 weeks after the androgen therapy (Fig. 7B), as
reported elsewhere (Sugimura et al., 1986b). By contrast,
androgen treatment failed to induce significant proliferation in
Fgfr2cn prostates (Fig. 7C,D), a marked contrast to control
prostates in which over 90% of luminal epithelial cells were
undergoing mitosis at day 2 after androgen treatment.
Accordingly, androgen replenishment also failed to induce
significant histological changes in Fgfr2cn prostates (Fig. 7B).
Although budding of the prostate is androgen dependent, prostatic
ductal morphogenesis in prenatal and neonatal stages is probably
controlled by a combination of chronic androgen stimulation and an
intrinsic ‘program’, which, because neonatal castration only impairs
approximately 60% of prostatic ductal branching (Donjacour and
Cunha, 1988), is not well-defined. To test whether ablation of
FGFR2 signaling altered the androgen dependency of neonatal
prostatic morphogenesis, neonatal castration was performed on
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Fig. 7. Fgfr2cn prostates
responded only weakly to
androgen replenishment.
(A) Gross tissue appearance of
dorsolateral prostates from Fgfr2cn
and control mice 2 weeks after
castration or uncastrated mice at
the same age. (B) HE staining of dlp
dissected from the mice 2 weeks
after castration (0 day) and at the
indicated days after the androgen
replenishment. (C) Sections were
immunostained with anti-PCNA
antibodies to reveal the proliferating
cells. Inserts: high-magnification
views of the same tissue. (D) The
mean percentage of PCNA-positive
cells in regenerating prostates was
calculated from three samples. Data
represents means of triplicate
samples. CN, Fgfr2cn mice; F/F,
Fgfr2flox homozygous mice.
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Fgfr2cn and control mice within 24 hours after birth. Results from 2-
and 4-week-old neonatally castrated mice showed that the prostate
continued to development in both Fgfr2cn and control mice, although
the size of the dlp lobes was significantly smaller than that of
uncastrated counterparts (Fig. 8A). Micro-dissection analyses
showed that the differences in complexity of the epithelial ductal
network between Fgfr2cn and control prostates were not curtailed.
Thus, the results indicate that disruption of the FGFR2 signaling axis
in the prostatic epithelium does not diminish androgen dependency
for neonatal branching morphogenesis or for the pubertal growth of
prostates. Together with adult tissue homeostasis data, the result
implies divergence in the control of prostatic branching
morphogenesis and growth, and of adult prostate tissue homeostasis,
by androgens.
A major function of prostates is to produce secretory proteins for
semen. HE staining showed that dp and lp lumens of Fgfr2cn
prostates had abundant eosinophilic substances (Fig. 3A), which
probably represent prostatic secretory proteins. SDS-PAGE analyses
of PBS-extracts from dlp lumens showed that, as in control prostates,
Fgfr2cn prostates produced abundant secretory proteins (Fig. 9A).
Western blot and real-time RT-PCR showed that Fgfr2cn prostates
also produced probasin and PSP94 (prostatic secretory protein of 94
amino acids; also known as MSMB – Mouse Genome Informatics),
although at reduced levels (Fig. 9B,C). Both probasin and PSP94 are
androgen-regulated secretory proteins of dorsolateral prostates in
rodents (Huizen et al., 2005; Imasato et al., 2001; Johnson et al.,
2000; Kasper and Matusik, 2000).
To clarify whether the secretory function of Fgfr2cn prostates is
regulated by androgen, prostate secretory proteins were extracted
from adult Fgfr2cn and control prostates 2 weeks after castration
and were analyzed as above. Results showed that the abundance
of total soluble proteins (Fig. 9A), and of probasin and PSP94
(Fig. 9B), were significantly reduced in both Fgfr2cn and control
prostates 2 weeks after castration, even though HE staining
showed that the lumen of Fgfr2cn prostates was packed with a
highly eosinophilic substance. The results suggest that the
eosinophilic substances in the prostate of castrated Fgfr2cn mice
were not PBS-extractable and, therefore, were not normal
prostatic secretory proteins. The results showed that, in both
control and Fgfr2cn prostates, the production of probasin and
PSP94, as well as other soluble secretory proteins, was controlled
by the androgens. Together, the data indicated that, although
ablation of the FGFR2 signaling axis in prostatic epithelium
diminished androgen activity in the regulation of homeostasis, it
did not abrogate androgen activity in the regulation of secretory-
protein production in prostates.
DISCUSSION
Disruption of Fgfr2 in prostate epithelium
impaired prostatic morphogenesis
Despite a large body of indirect evidence, direct demonstration of
FGFR2 kinase function in regulating prostatic development, as well
as insight into how FGFR2 cross-talks with the androgen signaling
axis, has been hampered by its essential role in early embryonic
development (De Moerlooze et al., 2000; Xu et al., 1998; Yu et al.,
2003). Here, we report that tissue-specific disruption of FGFR2 in
prostate epithelium at E17.5 significantly impairs prostatic
development. Most Fgfr2cn mice developed only two dorsal and two
lateral lobes of the prostate instead of the normal eight lobes (two
anterior, two dorsal, two lateral and two ventral). Although prostates
devoid of FGFR2 in the epithelium retained general prostate-tissue
architecture and were active in generating secretory proteins, the
epithelial compartment of Fgfr2cn prostates had a poorly developed
ductal structure characterized by less-extensive intra-ductal
infolding, suggesting that the disruption of FGFR2 in the epithelium
impaired branching morphogenesis.
The FGF10-FGFR2 signaling axis is important for
prostate branching morphogenesis 
The finding that ablation of FGFR2 in prostate epithelia significantly
inhibits prostate branching morphogenesis is consistent with the
notion that FGF10 functions as a mesenchymal paracrine regulator
of epithelial growth in the prostate (Thomson and Cunha, 1999).
However, prostatic phenotypes in Fgfr2cn mice were generally less
severe than in Fgf10-null mice, because, with a few exceptions that
exhibit poorly developed rudimentary prostatic buds, most Fgf10-
null embryos lack prostatic buds (Donjacour et al., 2003).
Furthermore, ex-vivo cultures of Fgf10-null urogenital sinus show
that Fgf10-null phenotypes can not be rescued by FGF10 alone, and
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Fig. 8. Prostate development in Fgfr2cn and control mice was
partially inhibited by neonatal castration. Left panels: gross tissue
appearance of prostates from Fgfr2cn and control mice at the indicated
ages with or without neonatal castration. Right panels: the same tissues
were micro-dissected to reveal detailed ductal structures. CN, Fgfr2cn
mice; F/F, Fgfr2flox homozygous mice. Scale bars: 1 mm. 
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can only be partially rescued by FGF10 together with testosterone,
suggesting that FGF10 deficiency may cause other defects as well
as those in the epithelial compartment. Thus, the mechanism
underlying Fgf10-null phenotypes in prostates is not simple. Here,
we show that NKX3.1-Cre only efficiently excised floxed sequences
in epithelial cells in prostatic rudiments in the urogenital sinus;
therefore, the defects in Fgfr2cn prostates were probably direct
phenotypes of a deficiency in FGF10 and/or FGFR2 signals. Thus,
Fgfr2cn prostates provide a good model to assess FGF10 and FGFR2
signaling axis in prostate development and function.
Ablation of Fgfr2 diminished androgen
dependency with respect to tissue homeostasis
but not to secretory function
In contrast to adult wild-type prostates, which were stringently
androgen dependent, tissue homeostasis in adult Fgfr2cn prostates
was less androgen dependent; androgen deprivation failed to induce
tissue degeneration in adult Fgfr2cn prostates within 2 weeks.
Neonatal prostatic morphogenesis is controlled by both androgen
dependent and independent mechanisms (Donjacour and Cunha,
1988). Androgen-independent regulation is probably diminished
during development because adult prostates are strictly androgen
dependent. Interestingly, ablation of FGFR2 did not alter androgen
dependency for neonatal branching morphogenesis and pubertal
growth of the prostate. Together, the results suggest that FGFR2
signaling is important not only for prostate organogenesis and
growth, but also for the prostate to be developed into a strict
androgen-dependent organ with respect to tissue homeostasis.
Interestingly, AR expression remained intact in both the epithelial
and stromal compartments of Fgfr2cn prostates, and the androgen
signaling axis remained active in controlling secretory-protein
production in mutant prostates. Thus, it appears that the androgen
signaling axis regulates tissue homeostasis and function through
different pathways.
The AR in mesenchymal cells is both essential and sufficient
for promoting epithelial branching morphogenesis and growth
during prostate development (Cunha et al., 2004). Function of the
epithelial AR is not understood, although it has been reported to
be required for stromal cell differentiation (Thomson, 2001). Data
from our present study suggest that the androgen may regulate
tissue homeostasis and the production of secretory protein
through different mechanisms; it is also androgens that regulate
the secretory function of epithelial cells directly through AR
signaling pathways within the cells, and that regulate tissue
homeostasis through bidirectional communication between the
stromal and epithelial compartments. The stromal AR-mediated
signals for prostate development and homeostasis have been
proposed to be mediated by paracrine growth factors that have
been referred to as andromedins. Although FGF7 and FGF10 are
proposed to be candidate andromedins in rat prostate-tumor
models (Lu et al., 1999; Yan et al., 1992), and ablation of FGF10
disrupts the development of male secondary sex organs, including
the prostate (Donjacour et al., 2003), no evidence shows that the
expression of FGF10 is androgen regulated in normal prostates
(Thomson, 2001; Thomson and Cunha, 1999). Thus, whether
FGF10 functions as an andromedin for prostate development
remains unknown. Although this study did not address the
andromedin issue, the data here demonstrates that FGFR2 signals
are important for prostate to develop into a strictly androgen-
dependent organ.
Reduced p63-positive basal cells in the Fgfr2cn
prostate 
p63-expressing basal cells are a small population of epithelial cells
localized as a discontinuous layer between the luminal epithelial
cells and the basement membrane, and which account for
approximately 10% of cells in mature prostate epithelium. The
prostatic basal compartment has been proposed to consist of a pool
of cellular subtypes, including tissue stem cells and
transient/amplifying progenitor cells, which give rise to terminally
differentiated cells (Lam and Reiter, 2006; Rizzo et al., 2005; Tokar
et al., 2005). However, the cell-lineage relationship between luminal
and basal cells is unclear because the elimination of basal cells by
p63 ablation does not affect neuroendocrine (NE)- and luminal-
epithelial cell populations (Kurita et al., 2004). Here, we show that
prostate rudiments and growing prostates exhibit a higher ratio of
basal:luminal epithelial cells, the population of which was gradually
reduced as prostates matured (Fig. 4B). Disruption of the FGFR2
signaling axis in prostates significantly reduced the basal cell
population, especially in mature prostates. FGF7 has been suggested
to have a negative effect on the maintenance of basal cell properties
in cell culture by promoting differentiation (Heer et al., 2006).
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Fig. 9. Production of secretory proteins in Fgfr2cn
prostates remained androgen dependent. (A) Profiles
of secretory proteins. The PBS-extracted proteins from the
dlp of 2-month-old mice were separated on 5-20%
gradient SDS-PAGE and stained with Coomassie Brilliant
Blue G250. (B) Expression of probasin and PSP94 in
Fgfr2cn prostates. The PBS-extracted proteins from
castrated or uncastrated mice were separated on SDS-
PAGE and were western blotted with anti-probasin and
anti-PSP94 antibodies, as indicated. (C) Total RNA was
extracted from adult Fgfr2cn and control prostates, and
expression of probasin and PSP94 was determined by real-
time RT-PCR. Expression levels were normalized to -actin
loading controls. The expression of each gene in control
prostates was set to 1. Data are mean±s.d. of three
independent experiments. F/F, homozygous Fgfr2flox mice;
CN, Fgfr2cn mice.
D
E
V
E
LO
P
M
E
N
T
However, our results suggest that FGFR2 signaling is most probably
essential for maintaining basal cell populations in the prostate.
Because NKX3.1-Cre was expressed in both basal and luminal
epithelial cells, it is possible that FGFR2 either directly controls the
basal cell population and their fate-determination within the cells, or
indirectly controls this population through regulatory
communications between luminal and basal epithelial cells. Further
efforts are needed to address this issue. 
Development of dlp is less dependent on FGFR2
signaling 
Experiments with the ROSA26 reporter indicated that NKX3.1-
Cre was expressed in all buds concomitantly between E17.25 and
E17.5, indicative that the Fgfr2 alleles were ablated in all
prostatic buds at the same time. Similar to previous reports
(Cunha et al., 2004; Thomson, 2001), data in Fig. 2A show that
the buds for each prostatic lobe appeared at E17.5. No significant
difference was noticeable between Fgfr2cn and control prostates
at this stage. The defects in ap and vp lobe development in
Fgfr2cn mice apparently occurred between E17.5 and E18.5.
Together with the notion that FGFR2IIIB is expressed from the
central to the distal tips of the elongating ducts in every prostatic
bud during branching morphogenesis (Huang et al., 2005), the
results indicate that the development of ap and vp buds is more
FGFR2-signal dependent than dlp buds, and that the function of
FGFR2 in rodent prostates is lobe-specific. Future experiments
with FGFR2IIIB-isoform-null mice will be carried out to validate
this finding. Differential responses to regulatory signals among
the prostatic lobes are not uncommon in rodent. For example,
treating pregnant females with ligands for aryl hydrocarbon
receptors also exhibits a lobe-specific inhibition of prostate
branching morphogenesis in mouse (Ko et al., 2002); and
ablation of HOXA10 in mice causes partial ap-dlp transformation
(Marker et al., 2001; Podlasek et al., 1999).
It appears that, relative to other prostatic lobes, the dlp has more
potential to escape from strict regulation by the FGFR2 and
androgen signaling axes with respect to growth and tissue
homeostasis. With regards to tissue structure, the dlp in rodents is
the most similar to the peripheral zone of human prostates, where
most prostate cancer arises. Together with the fact that the majority
of malignant prostate cancers lose FGFR2 expression and are not
androgen responsive (Giri et al., 1999a; Kwabi-Addo et al., 2001;
McKeehan et al., 1998; Wang and McKeehan, 2003), and that
disruption of the FGFR2 signaling axis has been associated with the
progression of prostate lesions in mouse models (Jin et al., 2003a;
Polnaszek et al., 2003), the results support a model in which the loss
of FGFR2 signaling contributes to the escape from androgen
regulation in prostate cancer cells. 
Prostate development is orchestrated by multiple signaling
pathways, including SHH, Notch, BMPs and FGFs. FGF10 has been
shown to regulate the expression of multiple morphoregulatory
genes, including SHH, BMP4, BMP7, HOXB13 and NKX3.1
(Huang et al., 2005). Here, we demonstrate that, at the mRNA level
in Fgfr2cn prostates, the expression of SHH, BMP7, NKX3.1, Notch,
HOXB13, -catenin, Foxa1, FGF7 and FGF10 was similar to that
seen in control prostates; and that of TGF-, BMP4 and Hox D13
was reduced. NKX3.1-Cre mice carry a Cre knock-in allele that is
also null for NKX3.1, which causes slight changes in prostate ductal
morphogenesis, as well as in secretory-protein expression, in ap and
vp lobes (Y.P.H., S. M. Price, Z. Chen, W. A. Banach-Petrosky, C.
Abate-Shen and M.M.S., unpublished). Quantitative RT-PCR results
show no significant changes in NKX3.1 expression in the dlp of
Fgfr2cn mice, indicating that the abnormalities in prostate
organogenesis and androgen dependency were independent of
NKX3.1 heterozygosity.
In summary, the FGFR2 tyrosine kinase plays a major role in
tissue organogenesis and androgen regulation in prostates. Prostates
devoid of epithelial resident FGFR2 responded poorly to androgens
with respect to cellular homeostasis. Thus, the results suggest that
cross-talk between FGFR2 and androgen signaling axes is important
for prostate development, tissue homeostasis and tissue function.
These results also provide a hint for how advanced prostate cancer
escapes strict regulation by androgens.
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